SCHEMBL9534759

SCHEMBL9534759

CN(C)/C=N/c1c(C=O)c(=O)n(C)c(=O)n1C

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.39
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.36
AOC3 Q16853 5/20 0.35
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ALDH1A1 P00352 4/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KDM4E B2RXH2 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9534763 1.00 THRB (0.39) THRBLMNAMAPTAOC3KMT2A
SCHEMBL10370092 0.74 MAPT (0.43) THRBLMNAMAPTKMT2AMEN1
SCHEMBL10370093 0.74 MAPT (0.43) THRBLMNAMAPTKMT2AMEN1
SCHEMBL15332519 0.69 AOC3 (0.42) MAPTAOC3KMT2AMEN1L3MBTL1
SCHEMBL9535687 0.69 LMNA (0.40) LMNAMAPTAOC3KMT2AMEN1
SCHEMBL9535682 0.69 LMNA (0.40) LMNAMAPTAOC3KMT2AMEN1
SCHEMBL3791186 0.66 ALDH1A1 (0.40) LMNAMAPTAOC3KMT2AMEN1
SCHEMBL474385 0.65 KMT2A (0.49) LMNAMAPTAOC3KMT2AMEN1
SCHEMBL1029816 0.65 KMT2A (0.43) LMNAMAPTAOC3KMT2AMEN1
SCHEMBL2556702 0.63 AOC3 (0.36) MAPTAOC3KMT2AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0243311-B1 Pyrido[2,3-d]pyrimidine derivatives NIPPON ZOKI PHARMACEUTICAL CO. LTD. (JP) 1993-06-09 EP disclosed
US-4808587-A ANTIALLEGENS NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 1989-02-28 US disclosed
EP-0243311-A2 Pyrido[2,3-d]pyrimidine derivatives NIPPON ZOKI PHARMACEUTICAL CO. LTD. (JP) 1987-10-28 EP disclosed